about
Synthesis and exploration of novel radiolabeled bombesin peptides for targeting receptor positive tumor.Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy.A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes.Therapeutic implication of 'Iturin A' for targeting MD-2/TLR4 complex to overcome angiogenesis and invasion.A peptide-modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma modelExosome as a Novel Shuttle for Delivery of Therapeutics across Biological BarriersTargeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastomaPro-survival autophagy: An emerging candidate of tumor progression through maintaining hallmarks of cancerLumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma
P50
Q40371740-02F18CB7-05B7-454C-9DC2-F0019F42CC1DQ45049679-96925413-2EC0-4426-97C2-08F6079615B7Q47150459-5E99C153-5650-49BF-BFC1-DFBA0F2E8ECBQ50769962-42DAF7E8-064B-4EEF-9133-E2704D9002D6Q63989078-C1FC5488-7CDD-41BD-B2B3-73613CCBA80BQ90248874-6BAEAB64-4978-4C26-8DED-3AFF8FC799F5Q92457633-142F4D4E-C220-4640-8B55-D8221646A44FQ92728545-2E951229-3496-4EBC-B84E-708C30E59945Q94686069-695FC9DC-A5F1-464A-A50A-06758A9586C6
P50
description
researcher ORCID 0000-0002-9396-8306
@en
wetenschapper
@nl
name
Indranil Banerjee
@ast
Indranil Banerjee
@en
Indranil Banerjee
@nl
type
label
Indranil Banerjee
@ast
Indranil Banerjee
@en
Indranil Banerjee
@nl
prefLabel
Indranil Banerjee
@ast
Indranil Banerjee
@en
Indranil Banerjee
@nl
P106
P31
P496
0000-0002-9396-8306